Key result
Review outlines the clinical role and use of PCSK9 inhibitors in advanced HF and heart transplantation.
Answers are grounded in this paper and cite their sources.
Open access journal discussing the impact of PCSK9 inhibitors on heart failure and transplantation outcomes.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Agdamag et al. (2020) studied this question. PCSK9 inhibitors are reviewed for their clinical use and therapeutic role in patients with advanced heart failure and heart transplant recipients.
Synapse has enriched 10 related papers. Consider them for comparative context: